Africans Struggled to Get COVID-19 Tests – What Must Change Before the Next Pandemic? 26/01/2023 Kerry Cullinan Most Africans could not get a COVID-19 test unless they were hospitalised or could afford to pay a private laboratory for a pricey test – yet rapid tests were being dished out free in the US and Europe. High prices, slow regulatory approval, and outdated ideas about self-testing were some of the barriers that prevented […] Continue reading -> Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Efforts to Harmonize Regulation of Medicines Are Making Progress 13/12/2022 Jessica Ahedor Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need. The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading -> As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Government Halts Production at Pharma Firm that WHO Says Produced Tainted Cough Medicines 13/10/2022 Elaine Ruth Fletcher The Indian government has halted the Maiden Pharmaceuticals plant that produced the cough and cold syrups that WHO says were tainted with toxic chemicals – possibly linked to the recent deaths of some 66 children in The Gambia. A senior WHO official confirmed that Indian government health authorities had shut down the plant after WHO […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Urged to Buy At Least 30% of Vaccines From African Manufacturers 03/10/2022 Paul Adepoju Global vaccine purchasing mechanisms including Gavi and the United Nations have been urged to purchase a minimum of 30% of their vaccines from African manufacturers, according to a resolution, Call to Action: Africa’s new public health order adopted by African member states on the sidelines of the recent United Nations general assembly (UNGA). The resolution, […] Continue reading -> After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older posts